Skip to main content

Breast Cancer

Ausgabe 1/2023

Inhalt (18 Artikel)

Editorial

A message from the new editor-in-chief

Takayuki Ueno

Review Article

The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis

Kenji Sekiguchi, Minako Sumi, Anneyuko Saito, Sadamoto Zenda, Satoko Arahira, Keiko Iino, Masayuki Okumura, Fujimi Kawai, Keiko Nozawa

Correction

Correction to: The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis

Kenji Sekiguchi, Minako Sumi, Anneyuko Saito, Sadamoto Zenda, Satoko Arahira, Keiko Iino, Masayuki Okumura, Fujimi Kawai, Keiko Nozawa

Review Article

Conservative axillary surgery is emerging in the surgical management of breast cancer

Masakuni Noguchi, Masafumi Inokuchi, Miki Yokoi-Noguchi, Emi Morioka, Yusuke Haba

Open Access Original Article

Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study

Carol Mansfield, Willings Botha, Gerard T. Vondeling, Kathleen Klein, Kongming Wang, Jasmeet Singh, Michelle D. Hackshaw

Original Article

Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients

Takaaki Konishi, Masahiko Tanabe, Nobuaki Michihata, Hiroki Matsui, Kotoe Nishioka, Kiyohide Fushimi, Yasuyuki Seto, Hideo Yasunaga

Original Article

Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery

Yidan Zhu, Takayuki Iwamoto, Yukiko Kajiwara, Yuko Takahashi, Mariko Kochi, Tadahiko Shien, Naruto Taira, Shinichi Toyooka, Hiroyoshi Doihara

Open Access Original Article

Cost-effectiveness of clinical breast examination screening programme among HER2-positive breast cancer patients: a modelling study

Tran T. Ngan, Siobhán Browne, Martha Goodwin, Hoang Van Minh, Michael Donnelly, Ciaran O’Neill

Original Article

Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node

Ning Liao, Cheukfai Li, Li Cao, Yanhua Chen, Chongyang Ren, Xiaoqing Chen, Hsiaopei Mok, Lingzhu Wen, Kai Li, Yulei Wang, Yuchen Zhang, Yingzi Li, Jiaoyi Lv, Fangrong Cao, Yuting Luo, Hongrui Li, Wendy Wu, Charles M. Balch, Armando E. Giuliano

Open Access Original Article

Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies

Yutaka Yamamoto, Hiroyasu Yamashiro, Andreas Schneeweiss, Volkmar Müller, Oleg Gluz, Peter Klare, Bahriye Aktas, Dank Magdolna, László Büdi, Béla Pikó, László Mangel, Masakazu Toi, Satoshi Morita, Shinji Ohno

Original Article

Sarcopenia detected with bioelectrical impedance versus CT scan and chemotherapy tolerance in patients with early breast cancer

Gabriel F. P. Aleixo, Stephanie A. Valente, Wei Wei, Po-Hao Chen, Halle C. F. Moore

Original Article

Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants

Kinuko Ohneda, Yohei Hamanaka, Hiroshi Kawame, Nobuo Fuse, Fuji Nagami, Yoichi Suzuki, Yumi Yamaguchi-Kabata, Muneaki Shimada, Atsushi Masamune, Yoko Aoki, Takanori Ishida, Masayuki Yamamoto

Open Access Original Article

The feasibility of pelvic floor training to treat urinary incontinence in women with breast cancer: a telehealth intervention trial

Udari N. Colombage, Sze-Ee Soh, Kuan-Yin Lin, Jennifer Kruger, Helena C. Frawley

Open Access Original Article

A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy

Shozo Ohsumi, Reiki Nishimura, Norikazu Masuda, Sadako Akashi-Tanaka, Kimito Suemasu, Hideko Yamauchi, Eriko Tokunaga, Tadashi Ikeda, Tsunehiro Nishi, Hiroto Hayashi, Yuichi Iino, Yuichi Takatsuka, Yasuo Ohashi, Hideo Inaji

Open Access Original Article

The effects of home-based exercise therapy for breast cancer-related fatigue induced by radical radiotherapy

Georgios Mavropalias, Prue Cormie, Carolyn J. Peddle-McIntyre, Daniel A. Galvão, Dennis R. Taaffe, Christelle Schofield, Sharon Ray, Yvonne Zissiadis, Robert U. Newton

Original Article

Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy

Kanako Suzuki, Shinsuke Sasada, Hiromi Nishi, Yuri Kimura, Tomoaki Shintani, Akiko Emi, Norio Masumoto, Takayuki Kadoya, Hiroyuki Kawaguchi, Morihito Okada

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.